Disposition of 11723 shares by Dallan Murray of Sarepta Therapeutics at 128.67 subject to Rule 16b-3
| S1RP34 Stock | BRL 31.35 0.72 2.35% |
About 55% of Sarepta Therapeutics' investors are presently thinking to get in. The analysis of current outlook of investing in Sarepta Therapeutics suggests that some traders are interested regarding Sarepta Therapeutics' prospects. The current market sentiment, together with Sarepta Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Sarepta Therapeutics stock news signals to limit their universe of possible portfolio assets.
Sarepta |
Filed transaction by Sarepta Therapeutics Officer Chief Customer Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Sarepta Therapeutics Fundamental Analysis
We analyze Sarepta Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sarepta Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sarepta Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
Sarepta Therapeutics is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Sarepta Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sarepta Therapeutics stock to make a market-neutral strategy. Peer analysis of Sarepta Therapeutics could also be used in its relative valuation, which is a method of valuing Sarepta Therapeutics by comparing valuation metrics with similar companies.
Peers
Sarepta Therapeutics Related Equities
| Z1OM34 | Zoom Video | 1.29 | ||||
| HOME34 | Home Depot | 0.22 | ||||
| CTSH34 | Cognizant Technology | 0.31 | ||||
| LEVE3 | MAHLE Metal | 0.47 | ||||
| BMOB3 | Bemobi Mobile | 2.23 | ||||
| A1LG34 | Align Technology | 4.71 |
Complementary Tools for Sarepta Stock analysis
When running Sarepta Therapeutics' price analysis, check to measure Sarepta Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sarepta Therapeutics is operating at the current time. Most of Sarepta Therapeutics' value examination focuses on studying past and present price action to predict the probability of Sarepta Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sarepta Therapeutics' price. Additionally, you may evaluate how the addition of Sarepta Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |